Physician profile
Amy E Frank
NPI 1982650057
$1,041.04
in general payments reported to CMS, 2019-2025
11 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.47 · 2022: $271 · 2023: $260 · 2024: $32.32 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $443.67 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $205.48 | 2021-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $156.33 | 2025 | Korlym |
| Ibsa Pharma INC. | $53.98 | 2022-2024 | Tirosint, Tirosint, Licart |
| Antares Pharma, INC. | $44.62 | 2022 | |
| Evofem Biosciences, INC. | $33.37 | 2021-2022 | |
| Exact Sciences Corporation | $31.16 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $23.45 | 2023 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $18.59 | 2023 | Quviviq |
| Amneal Pharmaceuticals LLC | $16.52 | 2025 | Unithroid |
| Abbvie INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.